Membrane Receptors and Signal Transduction — MCQs
JAK-STAT kinase receptors are associated with?
A partial agonist has:
Which of the following act through tyrosine kinase receptor:
Which of the following statements best describes the mechanism of action of insulin on target cells?
Which of the following hormones uses cGMP as a second messenger?
Which of the following act through G protein coupled receptors?
A primigravida at 38 weeks of gestation has gone into labor. Oxytocin was started to augment labor. The second messenger system through which oxytocin acts is:
Proteoglycan present in the glomerular basement membrane is?
Which of the following binds to Tyrosine Kinase receptor?
Maximum fluidity of the cell membrane is due to?
Membrane Receptors and Signal Transduction Indian Medical PG Practice Questions and MCQs
Question 1: JAK-STAT kinase receptors are associated with?
- A. Ion channels
- B. Nuclear transcription (Correct Answer)
- C. IP3 - DAG
- D. cAMP
Explanation: ***Nuclear transcription*** - JAK-STAT signaling is a **ligand-activated pathway** that directly regulates gene transcription in response to cytokines and growth factors. - Upon activation, **STAT proteins** translocate to the nucleus to act as transcription factors, modulating gene expression. *Ion channels* - **Ion channels** are transmembrane proteins that allow the passage of ions across cell membranes, typically involved in electrical signaling. - Their activity is usually regulated by **voltage changes** or direct ligand binding, not primarily by JAK-STAT signaling. *IP3 - DAG* - The **inositol triphosphate (IP3)** and **diacylglycerol (DAG)** pathway is a second messenger system primarily activated by G protein-coupled receptors (GPCRs). - This pathway leads to intracellular **calcium release** and protein kinase C activation, distinct from JAK-STAT. *cAMP* - **cAMP** (cyclic adenosine monophosphate) is a common second messenger activated by GPCRs, leading to the activation of **protein kinase A (PKA)**. - This signaling cascade is distinct from the direct transcriptional role of the JAK-STAT pathway.
Question 2: A partial agonist has:
- A. High affinity with low intrinsic activity (Correct Answer)
- B. High affinity with no intrinsic activity
- C. Low affinity with high intrinsic activity
- D. Low affinity with low intrinsic activity
Explanation: ***High affinity with low intrinsic activity*** - A **partial agonist** binds to the receptor with **high affinity** [1] but elicits a submaximal response, indicating partial activation [1],[2]. - Its **intrinsic activity** is greater than zero but less than that of a full agonist [2]. *High affinity with no intrinsic activity* - This describes an **antagonist**, which binds to the receptor with **high affinity** but produces no biological effect (zero intrinsic activity). - An antagonist simply blocks the action of other agonists. *Low affinity with high intrinsic activity* - While binding affinity and intrinsic activity are distinct properties, a drug with **high intrinsic activity** typically produces a strong effect, and low affinity would mean a higher concentration is needed for that effect. This combination does not define a partial agonist. - A full agonist would have **high intrinsic activity**, but affinity can vary. *Low affinity with low intrinsic activity* - A drug with both **low affinity** and **low intrinsic activity** would be a very weak partial agonist, requiring high concentrations to produce only a small effect. - While it technically describes a type of partial agonist, the defining characteristic of a partial agonist is often highlighted by its ability to bind effectively (high affinity) but only partially activate (low intrinsic activity) a receptor.
Question 3: Which of the following act through tyrosine kinase receptor:
- A. GH
- B. FSH
- C. Glucagon
- D. Insulin (Correct Answer)
Explanation: ***Insulin*** - **Insulin** binds to its specific receptor, which is a **tyrosine kinase receptor**, leading to autophosphorylation and activation of downstream signaling pathways. - This activation results in glucose uptake, metabolism, and storage in target cells. *GH* - **Growth Hormone (GH)** primarily acts through **JAK/STAT signaling pathways** after binding to its receptor, which is a cytokine receptor, not a direct tyrosine kinase receptor. - The GH receptor itself does not possess intrinsic tyrosine kinase activity but rather recruits and activates associated kinases. *FSH* - **Follicle-stimulating hormone (FSH)** mediates its effects by binding to a **G protein-coupled receptor (GPCR)** on target cells. - Activation of the **GPCR** leads to the generation of **cAMP** as a second messenger, which then modulates cellular processes. *Glucagon* - **Glucagon** also acts through a **G protein-coupled receptor (GPCR)** on liver cells. - Binding of glucagon to its receptor activates **adenylyl cyclase**, leading to an increase in **cAMP** levels and subsequently increased glycogenolysis and gluconeogenesis.
Question 4: Which of the following statements best describes the mechanism of action of insulin on target cells?
- A. Insulin binds to a receptor on the outer surface of the plasma membrane, activating adenylate cyclase through the Gs protein.
- B. Insulin binds to a cytoplasmic receptor and is transferred as a hormone receptor complex to the nucleus to modulate gene expression.
- C. Insulin enters the cell and causes the release of calcium ions from intracellular stores.
- D. Insulin binds to a transmembrane receptor on the outer surface of the plasma membrane, activating the tyrosine kinase in the cytosolic domain of the receptor. (Correct Answer)
Explanation: ***Insulin binds to a transmembrane receptor on the outer surface of the plasma membrane, activating the tyrosine kinase in the cytosolic domain of the receptor.*** - **Insulin** is a **peptide hormone** and cannot freely pass through the lipid bilayer, thus it binds to a **transmembrane receptor** on the cell surface. - This binding leads to the activation of the receptor's intrinsic **tyrosine kinase activity** in the intracellular domain, initiating a signaling cascade. *Insulin binds to a cytoplasmic receptor and is transferred as a hormone receptor complex to the nucleus to modulate gene expression.* - This mechanism describes the action of **steroid hormones**, which are lipid-soluble and can cross the cell membrane, binding to **intracellular receptors**. - **Insulin** acts via a **cell surface receptor** and its downstream effects are mediated through signal transduction pathways, not direct nuclear translocation. *Insulin binds to a receptor on the outer surface of the plasma membrane, activating adenylate cyclase through the Gs protein.* - This mechanism is characteristic of **G-protein coupled receptors (GPCRs)**, which activate or inhibit enzymes like adenylate cyclase via G-proteins to produce second messengers like cyclic AMP. - The **insulin receptor** is a **receptor tyrosine kinase**, not a GPCR, and does not directly activate adenylate cyclase via Gs protein. *Insulin enters the cell and causes the release of calcium ions from intracellular stores.* - While some hormones and neurotransmitters can trigger the release of intracellular **calcium ions**, this is typically mediated by specific pathways (e.g., GPCRs linked to phospholipase C). - **Insulin** does not directly enter target cells to cause calcium release; its actions are primarily mediated through receptor tyrosine kinase signaling pathways.
Question 5: Which of the following hormones uses cGMP as a second messenger?
- A. Insulin
- B. Thyroxine
- C. Growth hormone
- D. Atrial natriuretic peptide (ANP) (Correct Answer)
Explanation: ***Atrial natriuretic peptide (ANP)*** - **ANP** binds to a receptor that has **guanylyl cyclase activity**, directly converting **GTP to cGMP**. - **cGMP** then acts as a second messenger, leading to vasodilation and increased sodium and water excretion. *Insulin* - **Insulin** primarily signals through a **tyrosine kinase receptor**, leading to phosphorylation cascades. - It does not directly use **cGMP** as a second messenger for its main effects. *Thyroxine* - **Thyroxine (T4)** and **triiodothyronine (T3)** are **thyroid hormones** (amino acid derivatives) that act directly on **intracellular nuclear receptors**. - They primarily regulate gene transcription and do not utilize **cGMP** as a second messenger. *Growth hormone* - **Growth hormone** binds to a **cytokine receptor** that activates the **JAK/STAT signaling pathway**. - Its downstream effects do not involve **cGMP** as a primary second messenger.
Question 6: Which of the following act through G protein coupled receptors?
- A. Ach Muscarinic receptors (Correct Answer)
- B. Insulin receptors
- C. Ach Nicotinic receptors
- D. GABA-A receptors
Explanation: ***Ach Muscarinic receptors*** - All five **muscarinic acetylcholine receptors (M1-M5)** are **G protein-coupled receptors (GPCRs)** that mediate the parasympathetic nervous system's effects. - Activation of these receptors leads to downstream signaling through various G proteins, influencing cellular functions like heart rate and smooth muscle contraction. *Insulin receptors* - Insulin receptors are **receptor tyrosine kinases (RTKs)**, not GPCRs. - Upon insulin binding, they undergo autophosphorylation and activate intracellular signaling cascades involving **IRS proteins**, leading to glucose uptake. *Ach Nicotinic receptors* - Nicotinic acetylcholine receptors are **ligand-gated ion channels**, not GPCRs. - They open an ion pore in response to acetylcholine binding, allowing ions like sodium to flow through, resulting in rapid depolarization. *GABA-A receptors* - GABA-A receptors are also **ligand-gated ion channels**, specifically anion channels that are permeable to chloride ions. - When GABA binds, they open, allowing chloride influx, which typically hyperpolarizes the neuron and inhibits neural activity.
Question 7: A primigravida at 38 weeks of gestation has gone into labor. Oxytocin was started to augment labor. The second messenger system through which oxytocin acts is:
- A. Tyrosine kinase
- B. Phospholipase C (IP3/DAG pathway) (Correct Answer)
- C. cGMP
- D. cAMP
Explanation: ***Phospholipase C (IP3/DAG pathway)*** - Oxytocin binds to its receptor, which is a **Gq protein-coupled receptor**. This activates **phospholipase C**. - **Phospholipase C** then hydrolyzes **phosphatidylinositol 4,5-bisphosphate (PIP2)** into **inositol triphosphate (IP3)** and **diacylglycerol (DAG)**, which act as second messengers to increase intracellular calcium and mediate myometrial contraction. *Tyrosine kinase* - **Tyrosine kinase receptors** are typically activated by growth factors (e.g., insulin, epidermal growth factor) and lead to phosphorylation cascades. - This mechanism is not primarily associated with the downstream signaling of **oxytocin receptors**. *cGMP* - **Cyclic guanosine monophosphate (cGMP)** is a second messenger primarily involved in signaling pathways initiated by **nitric oxide** and some peptide hormones. - It often acts to cause smooth muscle relaxation, which is contrary to oxytocin's role in uterine contraction. *cAMP* - **Cyclic adenosine monophosphate (cAMP)** is a common second messenger for many hormones that bind to **Gs protein-coupled receptors**. - Hormones such as **epinephrine (beta-adrenergic receptors)** and **glucagon** utilize cAMP, typically leading to different cellular responses than those of oxytocin.
Question 8: Proteoglycan present in the glomerular basement membrane is?
- A. Keratan sulfate 1
- B. Keratan sulfate 2
- C. Heparan sulfate (Correct Answer)
- D. Chondroitin sulfate
Explanation: ***Heparan sulphate*** - Heparan sulphate is a key component of the **glomerular basement membrane** (GBM), crucial for its **negative charge and filtration function** [1][2]. - It plays a significant role in **filtration barrier** properties and affects the permeability of the GBM to proteins [1]. *Keratan sulphate 1* - Predominantly found in **cartilage** and **corneal tissue**, not associated with the glomerular basement membrane. - It contributes to **mechanical support** but lacks the essential role in renal filtration. *Keratan sulphate 2* - Similar to Keratan sulphate 1, this variant is involved in **cartilage** but not in the structure of the glomerular basement membrane. - Has distinct functions related to **tissue hydration** rather than the filtration dynamics of the GBM. *Chondroitin sulphate* - Commonly located in **cartilage** and connective tissues, it does not play a significant role in the structure of the glomerular basement membrane. - While it assists in **cell signaling** and regeneration, it does not influence the GBM permeability like heparan sulphate. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Kidney, pp. 905-907. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. With Illustrations By, pp. 34-35.
Question 9: Which of the following binds to Tyrosine Kinase receptor?
- A. Insulin (Correct Answer)
- B. Glucagon
- C. Prolactin
- D. Growth Hormone
Explanation: ***Insulin*** - **Insulin** is a classic example of a hormone that binds to and activates a **tyrosine kinase receptor**, leading to a cascade of intracellular signaling events for glucose uptake and metabolism. - The **insulin receptor** is a heterodimeric protein with intrinsic tyrosine kinase activity that phosphorylates itself and other proteins upon insulin binding. *Glucagon* - **Glucagon** primarily acts on **G protein-coupled receptors (GPCRs)**, specifically the glucagon receptor, to increase cyclic AMP (cAMP) and activate protein kinase A. - Its main roles are to stimulate **glycogenolysis** and **gluconeogenesis** in the liver. *Prolactin* - **Prolactin** binds to a receptor that is a member of the **cytokine receptor superfamily**, which lacks intrinsic enzyme activity. - Upon ligand binding, these receptors associate with and activate **Janus kinases (JAKs)**, leading to the JAK-STAT signaling pathway. *Growth Hormone* - **Growth hormone (GH)** also binds to a receptor belonging to the **cytokine receptor superfamily** (similar to prolactin), which then associates with and activates **JAKs**. - This activation subsequently initiates the **JAK-STAT signaling pathway**, mediating its diverse growth-promoting and metabolic effects.
Question 10: Maximum fluidity of the cell membrane is due to?
- A. palmitic acid
- B. alpha-linolenic acid
- C. arachidonic acid (Correct Answer)
- D. linoleic acid (18:2)
Explanation: ***arachidonic acid*** - **Arachidonic acid** is a polyunsaturated fatty acid (PUFA) with 20 carbons and 4 double bonds, denoted as C20:4. The presence of multiple **double bonds** creates kinks in the fatty acid tails, preventing tight packing of phospholipids in the membrane and thus increasing fluidity. - Cell membrane fluidity is enhanced by **unsaturated fatty acids** due to the presence of C=C double bonds. The more double bonds a fatty acid has (i.e., higher degree of unsaturation), the greater its contribution to membrane fluidity. Since arachidonic acid has the most double bonds among the options, it confers the greatest fluidity. *alpha-linolenic acid* - **Alpha-linolenic acid** is an omega-3 fatty acid (C18:3). While it is a **polyunsaturated fatty acid** and contributes to fluidity, it has fewer double bonds (3) than arachidonic acid (4), making it less effective in maximizing fluidity compared to arachidonic acid. - Its presence increases membrane fluidity, but not to the same extent as fatty acids with a higher degree of unsaturation. *linoleic acid (18:2)* - **Linoleic acid** (C18:2) is an omega-6 fatty acid with two double bonds. It contributes to membrane fluidity because it is unsaturated, but **less so than fatty acids with more double bonds** such as alpha-linolenic acid or arachidonic acid. - The fewer double bonds mean the fatty acid tails can pack a bit more closely, offering less fluidity compared to highly unsaturated fatty acids. *palmitic acid* - **Palmitic acid** is a **saturated fatty acid** (C16:0), meaning it has no double bonds. Saturated fatty acids have straight hydrocarbon chains that can pack tightly together in the cell membrane. - This tight packing **reduces membrane fluidity** and makes the membrane more rigid, which is the opposite of what maximizes fluidity.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free